Literature DB >> 30216525

Gestational diabetes incidence and delivery outcomes in Western China: A prospective cohort study.

Jonathan K L Mak1, Andy H Lee1, Ngoc Minh Pham1, Xiong-Fei Pan2, Li Tang3, Colin W Binns1, Xin Sun3.   

Abstract

BACKGROUND: Few studies have examined the age-standardized incidence of gestational diabetes mellitus (GDM) for comparison between populations. Information on delivery outcomes is also lacking for Chinese women with GDM. Therefore, the present study aimed to determine age-standardized GDM incidence and assess its association with maternal and neonatal outcomes.
METHODS: A total of 1901 pregnant women were recruited in Chengdu, Sichuan Province. GDM was diagnosed between 24 and 28 weeks' gestation using oral glucose tolerance tests. Age-standardized incidence rates of GDM were calculated using the direct method. Delivery outcomes were extracted from medical records and compared between the GDM and non-GDM groups.
RESULTS: The age-standardized GDM incidence was 18.3% (95% CI 15.6-21.1) and increased with maternal age and prepregnancy body mass index (BMI). Women with GDM experienced longer length of stay in hospital, shorter gestation at delivery, and a higher risk of cesarean delivery. Their newborns were more likely to be macrosomic or small for gestational age, and to require neonatal intensive care.
CONCLUSIONS: The incidence of GDM was high in Western China, especially among older and overweight women. Moreover, women with GDM had higher rates of adverse delivery outcomes. The findings lend further support for the screening, prevention, and management of GDM in Chinese women.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Chinese women; delivery outcomes; gestational diabetes; standardized incidence

Mesh:

Year:  2018        PMID: 30216525     DOI: 10.1111/birt.12397

Source DB:  PubMed          Journal:  Birth        ISSN: 0730-7659            Impact factor:   3.689


  7 in total

1.  Identification of the Active Compound of Liu Wei Di Huang Wan for Treatment of Gestational Diabetes Mellitus via Network Pharmacology and Molecular Docking.

Authors:  Yunqi Xiong; Qiutong Li; Xiuhui Chen; Ting Zhu; Qitian Lu; Guojing Jiang
Journal:  J Diabetes Res       Date:  2022-05-28       Impact factor: 4.061

2.  The Body Composition in Early Pregnancy is Associated with the Risk of Development of Gestational Diabetes Mellitus Late During the Second Trimester.

Authors:  Yanping Liu; Jing Liu; Yinjie Gao; Dan Zheng; Wei Pan; Min Nie; Liangkun Ma
Journal:  Diabetes Metab Syndr Obes       Date:  2020-07-06       Impact factor: 3.168

3.  Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis.

Authors:  Wenrui Ye; Cong Luo; Jing Huang; Chenglong Li; Zhixiong Liu; Fangkun Liu
Journal:  BMJ       Date:  2022-05-25

4.  The prevalence of gestational diabetes mellitus before and after the implementation of the universal two-child policy in China.

Authors:  Hui Zhu; Zhijia Zhao; Jin Xu; Yanming Chen; Qiong Zhu; Liming Zhou; Jie Cai; Lindan Ji
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-18       Impact factor: 6.055

5.  Subsidy programme for gestational diabetes mellitus screening and lifestyle management in rural areas of western China: a study protocol for a multicentre randomised controlled trial.

Authors:  Tingting Xu; Xiaozhen Lai; Kun He; Liangkun Ma; Hai Fang
Journal:  BMJ Open       Date:  2021-07-06       Impact factor: 2.692

6.  Upregulation of T Cell Receptor Signaling Pathway Components in Gestational Diabetes Mellitus Patients: Joint Analysis of mRNA and circRNA Expression Profiles.

Authors:  Yan-Ming Chen; Qiong Zhu; Jie Cai; Zhi-Jia Zhao; Bin-Bin Yao; Li-Ming Zhou; Lin-Dan Ji; Jin Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-03       Impact factor: 5.555

Review 7.  Gestational diabetes mellitus (GDM) and adverse pregnancy outcome in South Asia: A systematic review.

Authors:  Sabuj Kanti Mistry; Rajat Das Gupta; Sabiha Alam; Kuljeet Kaur; Abu Ahmed Shamim; Shuby Puthussery
Journal:  Endocrinol Diabetes Metab       Date:  2021-07-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.